文献速递神经肿瘤

用于胶质瘤诊断与监测的血液生物标志物

Blood-based biomarkers for the diagnosis and monitoring of gliomas.
PubMed 文献 · Neuro Oncol · 2018-01-01

本综述讨论胶质母细胞瘤监测中影像学假性进展的局限,并详述血液中循环肿瘤细胞、细胞外囊泡、循环肿瘤DNA和循环肿瘤RNA等候选生物标志物的现状与潜在影响,认为系列液体活检可用于研究肿瘤演化、耐药机制及监测治疗后的突变变化。

要点

  • 胶质母细胞瘤异质性高,活检可能无法反映全部特征。
  • MRI或CT监测可因假性进展而误导对治疗反应的判断。
  • 血液液体活检可辅助分子特征描述并识别真性进展。

核心结论

  • 系列液体活检为研究肿瘤演化、治疗耐药机制及监测治疗后的突变变化提供了独特机会。

研究设计与样本

  • 综述,未报告检索范围。

主要发现

  • 胶质母细胞瘤患者血液中存在循环肿瘤细胞、细胞外囊泡、循环肿瘤DNA和循环肿瘤RNA等候选循环生物标志物。
  • MRI或CT监测有效,但可因假性进展现象而有时产生误导。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Monitoring patient response to treatment is challenging for most cancers, but it is particularly difficult in glioblastoma multiform, the most common and aggressive form of malignant brain tumor. These tumors exhibit a high degree of heterogeneity which may not be reflected in a biopsy. To determine if the current standard of care is effective, glioma patients are monitored using MRI or CT scans, an effective but sometimes misleading approach due to the phenomenon of pseudoprogression. As such, there is incredible need for a minimally invasive "liquid biopsy" to assist in molecularly characterizing the tumors while also aiding in the identification of true progression in glioblastoma. This review details the status and potential impact for circulating tumor cells, extracellular vesicles, ctDNA, and ctRNA, putative circulating biomarkers found in the blood in glioblastoma patients. As mutation-based therapy becomes more prevalent in gliomas, blood-based analyses may offer a non-invasive method of identifying mutations. The ability to obtain serial "liquid biopsies" will provide unique opportunities to study the evolution of tumors and mechanisms of treatment resistance and monitor for mutational changes in response to therapy.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Zachariah MA, Oliveira-Costa JP, Carter BS, et al. Blood-based biomarkers for the diagnosis and monitoring of gliomas. Neuro Oncol. 2018. PMID: 29746665. doi:10.1093/neuonc/noy074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。